Breaking News Instant updates and real-time market news.

PRAH

PRA Health

$81.19

0.33 (0.41%)

, ABMD

Abiomed

$394.49

0.04 (0.01%)

17:24
05/25/18
05/25
17:24
05/25/18
17:24

PRA Health to replace Abiomed in the S&P 400 at open on May 31st

PRAH

PRA Health

$81.19

0.33 (0.41%)

ABMD

Abiomed

$394.49

0.04 (0.01%)

  • 30

    May

  • 05

    Jun

  • 12

    Jun

PRAH PRA Health
$81.19

0.33 (0.41%)

10/30/17
KEYB
10/30/17
NO CHANGE
Target $93
KEYB
Overweight
PRA Health price target raised to $93 from $86 at KeyBanc
KeyBanc analyst Donald Hooker raised his price target for PRA Health to $93 from $86 to reflect the stronger than expected trends at Symphony Health and over 15% EBITDA growth in 2018 and 2019. The analyst reiterates an Overweight rating on the shares.
12/11/17
LEHM
12/11/17
INITIATION
Target $94
LEHM
Overweight
PRA Health initiated with an Overweight at Barclays
Barclays analyst Jack Meehan started PRA Health Sciences with an Overweight rating and $94 price target. The analyst views the stock's valuation as attractive in the context of the company's "market-leading growth rates." He believes the integration of data into clinical trials is going to become a "need to have."
12/14/17
MUFG
12/14/17
INITIATION
Target $102
MUFG
Overweight
PRA Health initiated with an Overweight at MUFG
MUFG analyst Jason Twizell started PRA Health with an Overweight rating and $102 price target. The analyst finds the company's premium valuation justified given its high-teens percentage revenue growth outlook and "consistent" execution.
01/24/18
MZHO
01/24/18
DOWNGRADE
Target $86
MZHO
Neutral
PRA Health downgraded to Neutral from Buy at Mizuho
Mizuho analyst Ann Hynes downgraded PRA Health to Neutral citing valuation and trimmed its price target to $86 from $87.
ABMD Abiomed
$394.49

0.04 (0.01%)

02/22/18
PIPR
02/22/18
NO CHANGE
Target $300
PIPR
Overweight
Piper sees 'so much to like' at Abiomed, recommends buying shares
After hosting investor meetings with Abiomed management, Piper Jaffray analyst Matt O'Brien says "there is so much to like here." Management noted that the label expansions from last week were likely to expand the shock patient population by 20%-25%, O'Brien tells investors in a research note. He sees "significant room for growth" from Impella and keeps an Overweight rating on Abiomed shares with a $300 price target. The analyst continues to encourage investors to start or build positions.
04/04/18
GSCO
04/04/18
INITIATION
Target $332
GSCO
Buy
Abiomed initiated with a Buy at Goldman Sachs
Goldman Sachs analyst Issac Ro started Abiomed with a Buy rating and $332 price target.
04/25/18
PIPR
04/25/18
NO CHANGE
PIPR
Overweight
Piper says IPPS rates appear negative, but are really neutral for Abiomed
After Abiomed issued an 8k discussing the Centers for Medicare and Medicaid Services' proposed Inpatient Prospective Payment System, or IPPS, rates for Impella, Piper Jaffray analyst Matt O'Brien said the rates look negative "at first blush." However, when considering that very few Impella cases are billed to the DRG code for which the CMS proposed a cut of 24%, he said he views the proposed IPPS as "fairly neutral" for Abiomed. Adding that the code where most Impella cases are performed is proposed to be up about 3% in the current rule, O'Brien said he would take advantage of any weakness to start or build Abiomed positions. He keeps an Overweight rating on the shares.
05/03/18
PIPR
05/03/18
NO CHANGE
Target $360
PIPR
Overweight
Abiomed price target raised to $360 from $300 at Piper Jaffray
Piper Jaffray analyst Matt O'Brien raised his price target for Abiomed to $360 saying this morning's Q4 results easily beat his estimates. The momentum in using Impella to treat patients "remains strong" and there are new products and geographies that should continue to drive sales, O'Brien tells investors in a post-earnings research note. The analyst, while admitting the valuation is "hefty," reiterates an Overweight rating on Abiomed. He continues to encourage investors to own the name.

TODAY'S FREE FLY STORIES

MDT

Medtronic

$96.09

0.09 (0.09%)

10:05
09/18/18
09/18
10:05
09/18/18
10:05
Hot Stocks
Medtronic announces FDA approval for revised TAVR labeling, begins study »

Medtronic announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

TLRY

Tilray

$132.62

12.42 (10.33%)

10:03
09/18/18
09/18
10:03
09/18/18
10:03
Periodicals
Citron Research calls Tilray news 'promotional and misleading' »

Citron Research just…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBT

BB&T

$50.16

-0.08 (-0.16%)

10:01
09/18/18
09/18
10:01
09/18/18
10:01
Earnings
BB&T announces $5M investment in Enigma »

BB&T announced a $5M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

GIS

General Mills

$44.99

-2.78 (-5.82%)

10:00
09/18/18
09/18
10:00
09/18/18
10:00
Technical Analysis
Technical Take: General Mills falls sharply after earnings »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 28

    Oct

BBY

Best Buy

$77.25

0.22 (0.29%)

10:00
09/18/18
09/18
10:00
09/18/18
10:00
Options
Notable short-term option spreads in Best Buy »

Notable short-term option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACBFF

Aurora Cannabis

$0.00

(0.00%)

09:58
09/18/18
09/18
09:58
09/18/18
09:58
Hot Stocks
Aurora Cannabis trading in Canada halted, pending news »

The Investment Industry…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNP

Union Pacific

$164.22

7.49 (4.78%)

09:58
09/18/18
09/18
09:58
09/18/18
09:58
Conference/Events
Union Pacific to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 06

    Nov

UNP

Union Pacific

$164.03

7.3 (4.66%)

, FTI

TechnipFMC

$30.94

1.03 (3.44%)

09:55
09/18/18
09/18
09:55
09/18/18
09:55
Options
Early notable gainers among liquid option names on September 18th »

Notable gainers among…

UNP

Union Pacific

$164.03

7.3 (4.66%)

FTI

TechnipFMC

$30.94

1.03 (3.44%)

UHS

Universal Health

$131.36

5.33 (4.23%)

RIG

Transocean

$11.97

0.375 (3.23%)

HES

Hess Corp.

$68.20

1.41 (2.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 06

    Nov

09:55
09/18/18
09/18
09:55
09/18/18
09:55
General news
U.S. NAHB housing market index preview: »

U.S. NAHB housing market…

MBFI

MB Financial

$47.37

(0.00%)

, FITB

Fifth Third

$28.70

-0.01 (-0.03%)

09:50
09/18/18
09/18
09:50
09/18/18
09:50
Hot Stocks
MB Financial receives shareholder approval for merger with Fifth Third »

MB Financial (MBFI)…

MBFI

MB Financial

$47.37

(0.00%)

FITB

Fifth Third

$28.70

-0.01 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 23

    Oct

UNP

Union Pacific

$163.89

7.16 (4.57%)

09:49
09/18/18
09/18
09:49
09/18/18
09:49
Technical Analysis
Technical Take: Union Pacific moves to new high, analyst action »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

FATE

Fate Therapeutics

$11.06

(0.00%)

09:49
09/18/18
09/18
09:49
09/18/18
09:49
Recommendations
Fate Therapeutics analyst commentary  »

Fate Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

AZO

AutoZone

$717.00

-30.53 (-4.08%)

09:47
09/18/18
09/18
09:47
09/18/18
09:47
Hot Stocks
AutoZone falls -4.2% »

AutoZone is down -4.2%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 29

    Oct

BRC

Brady

$43.45

-1.9 (-4.19%)

09:47
09/18/18
09/18
09:47
09/18/18
09:47
Hot Stocks
Brady falls -3.8% »

Brady is down -3.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WK

Workiva

$34.60

-3.2 (-8.47%)

09:47
09/18/18
09/18
09:47
09/18/18
09:47
Hot Stocks
Workiva falls -8.9% »

Workiva is down -8.9%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

SMG

Scotts Miracle-Gro

$79.42

0.45 (0.57%)

09:47
09/18/18
09/18
09:47
09/18/18
09:47
Conference/Events
Scotts Miracle-Gro management to meet with SunTrust »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 19

    Sep

  • 20

    Sep

  • 21

    Sep

UNP

Union Pacific

$164.33

7.6 (4.85%)

09:47
09/18/18
09/18
09:47
09/18/18
09:47
Hot Stocks
Union Pacific rises 4.8% »

Union Pacific is up 4.8%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

CRC

California Resources

$38.68

1.91 (5.19%)

09:47
09/18/18
09/18
09:47
09/18/18
09:47
Hot Stocks
California Resources rises 5.5% »

California Resources is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

THO

Thor Industries

$109.35

11.78 (12.07%)

09:47
09/18/18
09/18
09:47
09/18/18
09:47
Hot Stocks
Thor Industries rises 12.3% »

Thor Industries is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

09:45
09/18/18
09/18
09:45
09/18/18
09:45
General news
Housing Market Index to be reported at 10:00 »

September Housing Market…

ATHN

Athenahealth

$143.26

(0.00%)

09:43
09/18/18
09/18
09:43
09/18/18
09:43
Periodicals
CNBC's Faber: Elliott may not have walked away from Athenahealth »

CNBC's David Faber…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELF

e.l.f. Beauty

$13.41

(0.00%)

, AVP

Avon Products

$2.09

(0.00%)

09:40
09/18/18
09/18
09:40
09/18/18
09:40
Periodicals
Dealreporter speculates on interest in e.l.f. Beauty after report about Avon »

After The Wall Street…

ELF

e.l.f. Beauty

$13.41

(0.00%)

AVP

Avon Products

$2.09

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 26

    Sep

  • 28

    Oct

DXJ

WisdomTree Japan Hedged Equity Fund

$55.06

(0.00%)

, SPWR

SunPower

$6.58

(0.00%)

09:40
09/18/18
09/18
09:40
09/18/18
09:40
Options
Unusually active option classes on open September 18th »

Unusual total active…

DXJ

WisdomTree Japan Hedged Equity Fund

$55.06

(0.00%)

SPWR

SunPower

$6.58

(0.00%)

ORCL

Oracle

$49.19

(0.00%)

FDX

FedEx

$255.80

(0.00%)

FIT

Fitbit

$5.45

(0.00%)

BBY

Best Buy

$77.03

(0.00%)

PEP

PepsiCo

$115.40

(0.00%)

TLT

iShares 20+ Year Treasury Bond Fund

$118.56

(0.00%)

XLI

Industrial Select Sector SPDR

$79.09

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 21

    Sep

  • 24

    Sep

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

  • 22

    Oct

CALM

Cal-Maine Foods

$51.00

0.15 (0.29%)

09:39
09/18/18
09/18
09:39
09/18/18
09:39
Recommendations
Cal-Maine Foods analyst commentary  »

Cal-Maine Foods estimates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPRO

GoPro

$6.38

0.165 (2.66%)

09:37
09/18/18
09/18
09:37
09/18/18
09:37
Conference/Events
GoPro to host product launch webcast »

Product Launch Webcast…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.